By Richard Berger There are early signs of recovery within the life sciences environment following a recent investment slowdown as venture capital is re-emerging, tenants are coming off the sidelines and average deal sizes are hitting all-time highs, according to a recent report from Cushman & Wakefield. Its research manager, Sandy Romero, said venture capital […]
by Paula Pintos The John A. Volpe National Transportation Systems Center was founded in 1970 to advance transportation innovation for the public good, and its new building in Cambridge, Massachusetts—designed and engineered by SOM—furthers this critical mission. Conceived as a vertical campus, this building brings the entirety of the U.S. Department of Transportation’s Volpe Center under one […]
BY REENA KARASIN Greentown Labs’ 200+ startups are developing, deploying, and commercializing climatetech solutions to decarbonize the key greenhouse-gas-emitting sectors—agriculture, buildings, electricity, manufacturing, and transportation—and build resilient communities. There’s an incredible amount of work and collaboration needed to get these technologies out of the lab and into the world, from early-stage funding, to pilot projects, to first commercial […]
By HOLLY DUTTON Six years ago, Opportunity Zones officially became a reality. The program was part of the Tax Cuts and Jobs Act of 2017, signed into law by former President Donald Trump in late December 2017. It was hailed as a success—a rare moment of bipartisanship that saw representatives on both sides of the […]
By Rachel Siegel and Jeff Stein After two years of relentless pressureover everything from sky-high inflation to a looming recession, the head of the Federal Reserve was asked this month what he does for fun. “For me, a big, big party — and I mean, this is really as fun as it gets — is a really […]
By Boston Restaurant Talk A new dining and drinking spot has come to Cambridge after being in the works for at least six years. According to an Instagram post from the place, Mothership is now open in the Alewife area of the city, moving into a building on CambridgePark Drive that is also home to a location […]
By Rowan Walrath In a first for the Nobel Prize-winning gene-editing technology, a CRISPR-based drug has been approved in the U.S. The Food and Drug Administration gave the green light Friday to exa-cel, a drug made by two Boston-based companies, Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and CRISPR Therapeutics Inc. (Nasdaq: CRSP). It will be marketed under […]
By Rowan Walrath Somerville’s bluebird bio Inc. has won its third U.S. drug approval since splitting into two companies. On Friday, the Food and Drug Administration approved lovo-cel, a gene therapy for sickle-cell disease. The drug will be marketed under the name Lyfgenia. The FDA announced Lyfgenia’s approval at the same time it said it had approved […]
By Greg Ryan One year ago almost to the day, the Nissenbaum family was on the brink of becoming $150 million richer. Things did not go as planned. For much of 2022, the Nissenbaums had a tentative deal in place to sell their car-parts junkyard near Somerville’s Union Square to the real estate developers building the […]
By Sam Goldfarb Wall Street is gearing up for rate cuts. Twenty months after the Federal Reserve began a historic campaign against inflation, investors now believe there is a much greater chance that the central bank will cut rates in just four months than raise them again in the foreseeable future. Interest-rate futures indicated Monday a 52% […]
